Skip to content
Disclosery

TAKEDA PHARMACEUTICAL CO LTD: PHAT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TAKEDA PHARMACEUTICAL CO LTD on PHAT, newest first. How the timeline and the estimate are built.

TAKEDA PHARMACEUTICAL CO LTD held 0 PHAT shares at 2024-09-30 per its 13F-HR filed 2025-02-13.

the latest 13F is the newest step

  1. period ended2024-09-30
    13F 0 shares
    Change vs previous 13F -1,557,063 shares

    13F-HR 0001395064-25-000030 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-06-30
    13F 1,557,063 shares
    Change vs previous 13F -1,596,154 shares

    6.9% of the 13F portfolio, value $16,037,749.

    13F-HR 0001395064-25-000028 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-03-31
    13F 3,153,217 shares
    Change vs previous 13F -4,306,069 shares

    11.59% of the 13F portfolio, value $33,487,165.

    13F-HR 0001395064-25-000026 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2023-12-31
    13F 7,459,286 shares
    Change vs previous 13F not available

    23.62% of the 13F portfolio, value $77,352,796.

    13F-HR 0001395064-25-000024 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).